0.1200
0.0000
(0.00%)
At close: January 16 at 4:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
40.6330
122.1120
3,519.6270
594.5630
16.5630
Cost of Revenue
183.9810
375.8450
2,114.2840
184.1810
11.2770
Gross Profit
-143.3480
-253.7330
1,405.3430
410.3820
5.2860
Operating Expense
14,765.4010
12,952.6630
15,381.5550
4,277.8080
1,445.7210
Operating Income
-14,908.7490
-13,206.3960
-13,976.2120
-3,867.4260
-1,440.4350
Net Non Operating Interest Income Expense
-482.4380
-144.1930
-53.5280
-18.6890
-10.1850
Other Income Expense
-741.6630
-419.1600
23.0500
-2.5470
-0.0030
Pretax Income
-16,132.8500
-13,769.7490
-14,006.6900
-3,888.6620
-1,450.6230
Tax Provision
0.8000
0.8000
--
--
--
Net Income Common Stockholders
-16,133.6500
-13,770.5490
-14,006.6900
-3,888.6610
-1,450.6230
Diluted NI Available to Com Stockholders
-16,133.6500
-13,770.5490
-14,006.6900
-3,888.6610
-1,450.6230
Total Operating Income as Reported
-14,908.7490
-13,206.3960
-13,976.2120
-3,867.4260
-1,440.4350
Total Expenses
14,949.3820
13,328.5080
17,495.8390
4,461.9890
1,456.9980
Net Income from Continuing & Discontinued Operation
-16,133.6500
-13,770.5490
-14,006.6900
-3,888.6610
-1,450.6230
Normalized Income
-15,537.6511
-13,339.1130
-14,006.6900
-3,888.6610
-1,450.6230
Interest Expense
482.4380
144.1930
53.5280
18.6890
10.1850
Net Interest Income
-482.4380
-144.1930
-53.5280
-18.6890
-10.1850
EBIT
-15,650.4120
-13,625.5560
-13,953.1620
-3,869.9730
-1,440.4380
EBITDA
-10,822.7140
-8,754.4990
-9,119.7340
-1,825.5260
-1,425.7400
Reconciled Cost of Revenue
183.9810
375.8450
2,114.2840
184.1810
11.2770
Reconciled Depreciation
4,827.6980
4,871.0570
4,833.4280
2,044.4470
14.6980
Net Income from Continuing Operation Net Minority Interest
-16,133.6500
-13,770.5490
-14,006.6900
-3,888.6610
-1,450.6230
Total Unusual Items Excluding Goodwill
-754.4290
-431.4360
--
--
--
Total Unusual Items
-754.4290
-431.4360
--
--
--
Normalized EBITDA
-10,068.2850
-8,323.0630
-9,119.7340
-1,825.5260
-1,425.7400
Tax Rate for Calcs
0.0002
--
--
--
--
Tax Effect of Unusual Items
-158.4301
--
--
--
--
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BDMDW Baird Medical Investment Holdings Limited
0.1300
+62.50%
SSKN STRATA Skin Sciences, Inc.
2.9100
-1.36%
HSCS HeartSciences Inc.
3.4700
+2.06%
TBIO Telesis Bio, Inc.
0.4200
0.00%
BBLG Bone Biologics Corporation
0.9601
+0.21%
XAIR Beyond Air, Inc.
0.4175
+11.57%
TNON Tenon Medical, Inc.
1.7900
+0.56%
AEMD Aethlon Medical, Inc.
0.6638
-7.10%
VTAK Catheter Precision, Inc.
0.4590
-1.29%
CUTR Cutera, Inc.
0.4770
+19.16%